ScoreWhy is UroGen Pharma Ltd. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 0.83% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -25.07
2
Negative results in Sep 25
- OPERATING CASH FLOW(Y) Lowest at USD -143.71 MM
- PRE-TAX PROFIT(Q) At USD -34.4 MM has Fallen at -45.88%
- NET PROFIT(Q) At USD -33.35 MM has Fallen at -40.87%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 42.62%, its profits have fallen by -42.7%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is UroGen Pharma Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
UroGen Pharma Ltd.
42.62%
0.31
114.34%
S&P 500
16.12%
0.84
19.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
90.67%
EBIT Growth (5y)
0.83%
EBIT to Interest (avg)
-25.07
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
1.58
Sales to Capital Employed (avg)
2.13
Tax Ratio
2.34%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-7.90
EV to EBIT
-6.80
EV to EBITDA
-6.91
EV to Capital Employed
-7.55
EV to Sales
9.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at USD -83.29 MM
NET SALES(Q)
Highest at USD 27.48 MM
-14What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -143.71 MM
PRE-TAX PROFIT(Q)
At USD -34.4 MM has Fallen at -45.88%
NET PROFIT(Q)
At USD -33.35 MM has Fallen at -40.87%
DEBTORS TURNOVER RATIO(HY)
Lowest at 4.54 times
Here's what is working for UroGen Pharma Ltd.
Net Sales
Highest at USD 27.48 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Here's what is not working for UroGen Pharma Ltd.
Operating Cash Flow
Lowest at USD -143.71 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD -34.4 MM has Fallen at -45.88%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -33.35 MM has Fallen at -40.87%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debtors Turnover Ratio
Lowest at 4.54 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
